Purchase Order 12913519P0021
Award Date 9/24/19
Potential Completion Date 12/24/19
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parlier, CA 93648, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
- The National Center for Advancing Translational Sciences (NCATS) awarded a $13.6K firm fixed-price purchase order to A&G Pharmaceutical, Inc. on September 24, 2025, for the generation of reagents against AZM-152, a drug candidate from the TDB AZOME project. The contract, which will be completed by September 23, 2026, was awarded without set-aside designation through open competition. Work will be performed at A&G Pharmaceutical's facility in Columbia, Maryland. A&G Pharmaceutical,...
- The National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, awarded a $18,500 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for laboratory testing, fusion, and cloning services. The contract has an ultimate completion date of November 30, 2024 and does not have a set-aside designation. This award is part of a larger $100 million Blanket Purchase Agreement (BPA)...
- This is a firm-fixed price Blanket Purchase Agreement (BPA) contract awarded by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for $100 million. The BPA allows various NIH institutes and the Department of Agriculture's Agricultural Research Service to place delivery orders for Precision Antibody's custom biological materials, laboratory and testing services, and animal testing...
- The U.S. government awarded a firm fixed-price purchase order valued at $4,500 to Biomatik USA, LLC for the synthesis of 10 grams of chemically synthesized peptide (Quote #SP7010521R2). The contract, awarded on March 16, 2017, with an ultimate completion date of April 20, 2017, was funded by a civilian federal agency through its Southeast Area office. The work was to be performed at Biomatik's facility located in Ottawa, Ontario, Canada. No set-aside designation was applied to this...
- This federal contract was awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for a COVID-19-related project analyzing a novel truncated form of the ACE2 receptor. The $19,349.65 firm-fixed-price purchase order was awarded on June 18, 2020, with a period of performance through June 19, 2020. The contract was awarded without any set-aside designation, indicating open competition....
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...
- This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...
- This federal contract award is for the CRUDE PEPTIDE SYNTHESIS, with a potential value of $22,593.00. The contract was awarded to A & A Labs LLC, doing business as Synthetic Biomolecules, a minority-owned, self-certified small disadvantaged business, and limited liability company. The contract is a purchase order with a firm fixed price, awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. The place of...
- Bio-Synthesis, Inc., operating as Dnaexam, received a $4,620 firm fixed-price purchase order from a civilian federal agency within the Pacific West Area for custom peptides. The contract, awarded on March 30, 2016, with an ultimate completion date of April 29, 2016, was performed at the company's Lewisville, Texas facility. No set-aside designation was applied to this award. Bio-Synthesis is a Hispanic American-owned, for-profit Subchapter S Corporation specializing in advanced biological...